Cover Image
Market Research Report

North America Pen Needles Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 910512
Published Content info 80 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Pen Needles Market: Industry Trends and Forecast to 2026
Published: August 1, 2019 Content info: 80 Pages
Description

North America pen needles market is projected to register a substantial CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Product Type (Standard Pen Needles, Safety Pen Needles), Product Length (Medium Length, Nano Length, Long Length), Usability (Disposable, Reusable), Application (Diabetes, Growth Hormone Deficiency, Others), Therapy (Insulin, Glucagon-Like Peptide-1, Growth Hormones, Others), End User (Home Healthcare, Hospitals, Clinics, Others), Country (U.S., Canada, Mexico)

Some of the major factors contributing to the growth of North America pen needles market:

  • High prevalence rate of diabetes mellitus in U.S
  • Increasing R&D expenditure

Market Players

The key market players for North America pen needles market are listed below:

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Terumo Corporation
  • MedExel Co., Ltd
  • ALLISON MEDICAL
  • VOGT MEDICAL
  • Digital Medics Pty Ltd.
  • STAT Medical Devices.
  • DOMREX Pharma Inc.
  • Menarini Diagnostics srl
  • Ypsomed AG
  • Braun Melsungen AG
  • Facet Medical Technologies
  • KD Medical GmbH
  • Haselmeier GmbH & Co. KG
  • pendiq GmbH
  • MedExel Co., Ltd
  • Owen Mumford Ltd.
  • HTL-STREFA S.A.
  • LDI, Ltd. LLC
  • Sanofi
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA PEN NEEDLES MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 NORTH AMERICA PEN NEEDLES MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 MULTIVARIATE MODELING
  • 2.8 PRODUCTS LIFELINE CURVE
  • 2.9 VENDOR SHARE ANALYSIS
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING PREVALENCE OF DIABETES
    • 3.1.2 INCREASING GERIATRIC POPULATION
    • 3.1.3 RISING GOVERNMENT INITIATIVES
  • 3.2 RESTRAINT
    • 3.2.1 PREFERENCE FOR ALTERNATIVE MODES OF DRUG DELIVERY
  • 3.3 OPPORTUNITIES
    • 3.3.1 RISE IN AWARENESS AMONG THE POPULATION
    • 3.3.2 INCREASING BIOSIMILAR DRUG AVAILABILITY
  • 3.4 CHALLENGES
    • 3.4.1 REUSE OF PEN NEEDLES
    • 3.4.2 STRICT REGULATORY REQUIREMENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 STANDARD PEN NEEDLES
  • 6.3 SAFETY PEN NEEDLES

7 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT LENGTH

  • 7.1 OVERVIEW
  • 7.2 MEDIUM LENGTH
  • 7.3 NANO LENGTH
  • 7.4 LONG LENGTH

8 NORTH AMERICA PEN NEEDLES MARKET, BY USABILITY

  • 8.1 OVERVIEW
  • 8.2 REUSABLE
  • 8.3 DISPOSABLE

9 NORTH AMERICA PEN NEEDLES MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 DIABETES
  • 9.3 GROWTH HORMONE DEFICIENCY
  • 9.4 OTHERS

10 NORTH AMERICA PEN NEEDLES MARKET, BY THERAPY

  • 10.1 OVERVIEW
  • 10.2 INSULIN
  • 10.3 GLUCAGON-LIKE PEPTIDE-1
  • 10.4 GROWTH HORMONES
  • 10.5 OTHERS

11 NORTH AMERICA PEN NEEDLES MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 HOME HEALTHCARE
  • 11.3 HOSPITALS
  • 11.4 CLINICS
  • 11.5 OTHERS

12 NORTH AMERICA PEN NEEDLES MARKET, BY GEOGRAPHY

  • 12.1 NORTH AMERICA
    • 12.1.1 U.S.
    • 12.1.2 CANADA
    • 12.1.3 MEXICO

13 NORTH AMERICA PEN NEEDLES MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 COMPANY PROFILE

  • 14.1 NOVO NORDISK A/S
    • 14.1.1 COMPANY SNAPSHOT
    • 14.1.2 REVENUE ANALYSIS
    • 14.1.3 COMPANY SHARE ANALYSIS
    • 14.1.4 PRODUCT PORTFOLIO
    • 14.1.5 RECENT DEVELOPMENTS
  • 14.2 SANOFI
    • 14.2.1 COMPANY SNAPSHOT
    • 14.2.2 REVENUE ANALYSIS
    • 14.2.3 COMPANY SHARE ANALYSIS
    • 14.2.4 PRODUCT PORTFOLIO
    • 14.2.5 RECENT DEVELOPMENTS
  • 14.3 ELI LILLY AND COMPANY
    • 14.3.1 COMPANY SNAPSHOT
    • 14.3.2 REVENUE ANALYSIS
    • 14.3.3 COMPANY SHARE ANALYSIS
    • 14.3.4 PRODUCT PORTFOLIO
    • 14.3.5 RECENT DEVELOPMENTS
  • 14.4 BD
    • 14.4.1 COMPANY SNAPSHOT
    • 14.4.2 REVENUE ANALYSIS
    • 14.4.3 COMPANY SHARE ANALYSIS
    • 14.4.4 PRODUCT PORTFOLIO
    • 14.4.5 RECENT DEVELOPMENTS
  • 14.5 A. MENARINI DIAGNOSTICS SRL
    • 14.5.1 COMPANY SNAPSHOT
    • 14.5.2 PRODUCT PORTFOLIO
    • 14.5.3 RECENT DEVELOPMENT

  • 14.6 ALLISON MEDICAL, INC.
    • 14.6.1 COMPANY SNAPSHOT
    • 14.6.2 PRODUCT PORTFOLIO
    • 14.6.3 RECENT DEVELOPMENT
  • 14.7 B. BRAUN MELSUNGEN AG
    • 14.7.1 COMPANY SNAPSHOT
    • 14.7.2 REVENUE ANALYSIS
    • 14.7.3 PRODUCT PORTFOLIO
    • 14.7.4 RECENT DEVELOPMENTS
  • 14.8 DIGITAL MEDICS PTY LTD
    • 14.8.1 COMPANY SNAPSHOT
    • 14.8.2 PRODUCT PORTFOLIO
    • 14.8.3 RECENT DEVELOPMENTS
  • 14.9 DOMREX PHARMA INC.
    • 14.9.1 COMPANY SNAPSHOT
    • 14.9.2 PRODUCT PORTFOLIO
    • 14.9.3 RECENT DEVELOPMENT
  • 14.10 FACET MEDICAL TECHNOLOGIES
    • 14.10.1 COMPANY SNAPSHOT
    • 14.10.2 PRODUCT PORTFOLIO
    • 14.10.3 RECENT DEVELOPMENT
  • 14.11 HTL- STREFA S.A.
    • 14.11.1 COMPANY SNAPSHOT
    • 14.11.2 PRODUCT PORTFOLIO
    • 14.11.3 RECENT DEVELOPMENTS
  • 14.12 KD MEDICAL GMBH HOSPITAL PRODUCTS
    • 14.12.1 COMPANY SNAPSHOT
    • 14.12.2 PRODUCT PORTFOLIO
    • 14.12.3 RECENT DEVELOPMENT
  • 14.13 LDI LTD., LLC
    • 14.13.1 COMPANY SNAPSHOT
    • 14.13.2 PRODUCT PORTFOLIO
    • 14.13.3 RECENT DEVELOPMENTS
  • 14.14 MEDEXEL CO., LTD.
    • 14.14.1 COMPANY SNAPSHOT
    • 14.14.2 PRODUCT PORTFOLIO
    • 14.14.3 RECENT DEVELOPMENT
  • 14.15 OWEN MUMFORD LTD
    • 14.15.1 COMPANY SNAPSHOT
    • 14.15.2 PRODUCT PORTFOLIO
    • 14.15.3 RECENT DEVELOPMENT
  • 14.16 PENDIQ GMBH
    • 14.16.1 COMPANY SNAPSHOT
    • 14.16.2 PRODUCT PORTFOLIO
    • 14.16.3 RECENT DEVELOPMENT
  • 14.17 STAT MEDICAL DEVICES.
    • 14.17.1 COMPANY SNAPSHOT
    • 14.17.2 PRODUCT PORTFOLIO
    • 14.17.3 RECENT DEVELOPMENT
  • 14.18 TERUMO CORPORATION
    • 14.18.1 COMPANY SNAPSHOT
    • 14.18.2 REVENUE ANALYSIS
    • 14.18.3 PRODUCT PORTFOLIO
    • 14.18.4 RECENT DEVELOPMENTS
  • 14.19 VOGT MEDICAL
    • 14.19.1 COMPANY SNAPSHOT
    • 14.19.2 PRODUCT PORTFOLIO
    • 14.19.3 RECENT DEVELOPMENT
  • 14.20 WILHELM HASELMEIER GMBH & CO. KG
    • 14.20.1 COMPANY SNAPSHOT
    • 14.20.2 PRODUCT PORTFOLIO
    • 14.20.3 RECENT DEVELOPMENTS
  • 14.21 YPSOMED AG
    • 14.21.1 COMPANY SNAPSHOT
    • 14.21.2 REVENUE ANALYSIS
    • 14.21.3 PRODUCT PORTFOLIO
    • 14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 COUNTRY VISE DIABETES CASES IN 2017
  • TABLE 2 COUNTRY VISE DIABETES CASES IN 2017
  • TABLE 3 NUMBER OF PEOPLE WITH DIABETES WORLDWIDE AND PER REGION IN 2017 AND 2045 (20-79 YEARS)
  • TABLE 4 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 5 AGEING LATIN AMERICA POPULATION (IN MILLION)
  • TABLE 6 NUMBER AND DISTRIBUTION OF PERSONS AGED 60 YEARS OR OVER BY REGION, IN 2017 AND 2050
  • TABLE 7 REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 8 DEVICES USED TO INJECT INSULIN IN BRAZIL, LATIN AMERICA AND THE WORLD
  • TABLE 9 REUSE PERCENTAGES AND REUSE FREQUENCY BY COUNTRY (IN PERCENTAGES)
  • TABLE 10 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 11 NORTH AMERICA STANDARD PEN NEEDLES IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 NORTH AMERICA SAFETY PEN NEEDLES IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT LENGTH, 2017-2026 (USD MILLION)
  • TABLE 14 NORTH AMERICA MEDIUM LENGTH IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 NORTH AMERICA NANO LENGTH IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 NORTH AMERICA LONG LENGTH IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 NORTH AMERICA PEN NEEDLES MARKET, BY USABILITY, 2017-2026 (USD MILLION)
  • TABLE 18 NORTH AMERICA REUSABLE IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 NORTH AMERICA DISPOSABLE IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 NORTH AMERICA PENNEEDLES MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 21 NORTH AMERICA DIABETES IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22 NORTH AMERICA GROWTH HORMONE DEFICIENCY IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 NORTH AMERICA OTHERS IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24 NORTH AMERICA PEN NEEDLES MARKET, BY THERAPY, 2017-2026 (USD MILLION)
  • TABLE 25 NORTH AMERICA INSULIN IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 NORTH AMERICA GLUCAGON-LIKE PEPTIDE-1 IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 27 NORTH AMERICA GROWTH HORMONES IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 NORTH AMERICA OTHERS IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 NORTH AMERICA PEN NEEDLES MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 NORTH AMERICA HOME HEALTHCARE IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 NORTH AMERICA HOSPITALS IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 NORTH AMERICA CLINICS IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 33 NORTH AMERICA OTHERS IN PEN NEEDLES MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 NORTH AMERICA PEN NEEDLES MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 35 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 36 NORTH AMERICA PEN NEEDLES MARKET, BY PRODUCT LENGTH, 2017-2026 (USD MILLION)
  • TABLE 37 NORTH AMERICA PEN NEEDLES MARKET, BY USABILITY, 2017-2026 (USD MILLION)
  • TABLE 38 NORTH AMERICA PEN NEEDLES MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 39 NORTH AMERICA PEN NEEDLES MARKET, BY THERAPY, 2017-2026 (USD MILLION)
  • TABLE 40 NORTH AMERICA PEN NEEDLES MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 41 U.S. PEN NEEDLES MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 42 U.S. PEN NEEDLES MARKET, BY PRODUCT LENGTH, 2017-2026 (USD MILLION)
  • TABLE 43 U.S. PEN NEEDLES MARKET, BY USABILITY, 2017-2026 (USD MILLION)
  • TABLE 44 U.S. PEN NEEDLES MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 45 U.S. PEN NEEDLES MARKET, BY THERAPY, 2017-2026 (USD MILLION)
  • TABLE 46 U.S. PEN NEEDLES MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 47 CANADA PEN NEEDLES MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 48 CANADA PEN NEEDLES MARKET, BY PRODUCT LENGTH, 2017-2026 (USD MILLION)
  • TABLE 49 CANADA PEN NEEDLES MARKET, BY USABILITY, 2017-2026 (USD MILLION)
  • TABLE 50 CANADA PEN NEEDLES MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 51 CANADA PEN NEEDLES MARKET, BY THERAPY, 2017-2026 (USD MILLION)
  • TABLE 52 CANADA PEN NEEDLES MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 MEXICO PEN NEEDLES MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
  • TABLE 54 MEXICO PEN NEEDLES MARKET, BY PRODUCT LENGTH, 2017-2026 (USD MILLION)
  • TABLE 55 MEXICO PEN NEEDLES MARKET, BY USABILITY, 2017-2026 (USD MILLION)
  • TABLE 56 MEXICO PEN NEEDLES MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 57 MEXICO PEN NEEDLES MARKET, BY THERAPY, 2017-2026 (USD MILLION)
  • TABLE 58 MEXICO PEN NEEDLES MARKET, BY END USER, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA PEN NEEDLES MARKET
  • FIGURE 2 NORTH AMERICA PEN NEEDLES MARKET: DATA VALIDATION MODEL
  • FIGURE 3 NORTH AMERICA PEN NEEDLES MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA PEN NEEDLES MARKET: NORTH AMERICA VS REGIONAL ANALYSIS
  • FIGURE 5 NORTH AMERICA PEN NEEDLES MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA PEN NEEDLES MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 NORTH AMERICA PEN NEEDLES MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PEN NEEDLES MARKET
  • FIGURE 9 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA PEN NEEDLES MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 10 INCREASING PREVALENCE OF DIABETES AND INCREASING NUMBER OF GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE NORTH AMERICA PEN NEEDLES MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 11 STANDARD PEN NEEDLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PEN NEEDLES MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 12 NORTH AMERICA PEN NEEDLES MARKET: BY PRODUCT TYPE
  • FIGURE 13 NORTH AMERICA PEN NEEDLES MARKET: BY PRODUCT LENGTH, 2018
  • FIGURE 14 NORTH AMERICA PEN NEEDLES MARKET: BY USABILITY, CAGR (2019-2026)
  • FIGURE 15 NORTH AMERICA PEN NEEDLES MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 16 NORTH AMERICA PEN NEEDLES MARKET: BY THERAPY, 2018
  • FIGURE 17 NORTH AMERICA PEN NEEDLES MARKET DOMINATE BY HOME HEALTHCARE (2018)
  • FIGURE 18 NORTH AMERICA PEN NEEDLES MARKET: SNAPSHOT (2018)
  • FIGURE 19 NORTH AMERICA PEN NEEDLES MARKET: BY COUNTRY (2018)
  • FIGURE 20 NORTH AMERICA PEN NEEDLES MARKET:BY COUNTRY (2019 & 2026)
  • FIGURE 21 NORTH AMERICA PEN NEEDLES MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 22 NORTH AMERICA PEN NEEDLES MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 23 NORTH AMERICA PEN NEEDLES MARKET: COMPANY SHARE 2018 (%)
Back to Top